tiprankstipranks
Advertisement
Advertisement

FDMT Stock Latest News

4D Molecular Therapeutics Buy Rating Reaffirmed on 4D-150 Pivotal Trial Momentum; Price Target Maintained at $36
Ratings4D Molecular Therapeutics Buy Rating Reaffirmed on 4D-150 Pivotal Trial Momentum; Price Target Maintained at $36
11d ago
FDMT
4D Molecular Therapeutics Secures $200 Million Loan Facility
PremiumCompany Announcements
4D Molecular Therapeutics Secures $200 Million Loan Facility
12d ago
8K
FDMT
4D Molecular completes enrollment in 4FRONT-2 trial
PremiumThe Fly
4D Molecular completes enrollment in 4FRONT-2 trial
12d ago
FDMT
4D Molecular Therapeutics Stockholders Back Directors and Governance
PremiumCompany Announcements
4D Molecular Therapeutics Stockholders Back Directors and Governance
19d ago
8K
FDMT
Analyst Reiterates Buy on 4D Molecular Therapeutics as Wet AMD Gene Therapy Advances, Keeps $36 Price Target Unchanged
PremiumRatings
Analyst Reiterates Buy on 4D Molecular Therapeutics as Wet AMD Gene Therapy Advances, Keeps $36 Price Target Unchanged
2M ago
FDMT
Daniel Giraldo Reiterates Buy on 4D Molecular Therapeutics, Citing Strong 4D-150 Progress and Undervalued Upside vs. $29 Price Target
PremiumRatingsDaniel Giraldo Reiterates Buy on 4D Molecular Therapeutics, Citing Strong 4D-150 Progress and Undervalued Upside vs. $29 Price Target
2M ago
FDMT
4D Molecular price target lowered to $33 from $38 at Goldman Sachs
Premium
The Fly
4D Molecular price target lowered to $33 from $38 at Goldman Sachs
2M ago
FDMT
4D Molecular files $400M mixed securities shelf
Premium
The Fly
4D Molecular files $400M mixed securities shelf
2M ago
FDMT
4D Molecular reports Q1 EPS ($1.01), consensus ($1.00)
PremiumThe Fly
4D Molecular reports Q1 EPS ($1.01), consensus ($1.00)
2M ago
FDMT
4D Molecular price target lowered to $23 from $45 at Evercore ISI
PremiumThe Fly
4D Molecular price target lowered to $23 from $45 at Evercore ISI
3M ago
FDMT
4D Molecular Therapeutics Consolidates Financial Leadership Under New Role
PremiumCompany Announcements
4D Molecular Therapeutics Consolidates Financial Leadership Under New Role
3M ago
8K
FDMT
4D Molecular assumed with a Buy at Jefferies
PremiumThe Fly
4D Molecular assumed with a Buy at Jefferies
3M ago
FDMT
Reimbursement and Pricing Pressures Threaten Commercial Outlook for 4D Molecular Therapeutics’ Gene Therapies
PremiumCompany AnnouncementsReimbursement and Pricing Pressures Threaten Commercial Outlook for 4D Molecular Therapeutics’ Gene Therapies
4M ago
FDMT
4D Molecular Therapeutics, Inc. (FDMT) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
4D Molecular Therapeutics, Inc. (FDMT) Q4 Earnings Cheat Sheet
5M ago
FDMT
4D Molecular completes enrollment for 4FRONT-1 Phase 3 trial
Premium
The Fly
4D Molecular completes enrollment for 4FRONT-1 Phase 3 trial
5M ago
FDMT
4D Molecular assumed with an Overweight at Barclays
PremiumThe Fly
4D Molecular assumed with an Overweight at Barclays
5M ago
FDMT
4D Molecular Therapeutics Restructures Equity via Warrant Exchange
PremiumCompany Announcements
4D Molecular Therapeutics Restructures Equity via Warrant Exchange
6M ago
8K
FDMT
4D Molecular announces employment inducement grants
PremiumThe Fly
4D Molecular announces employment inducement grants
6M ago
FDMT
4D Molecular Therapeutics Expands Leadership With New Director Appointment
PremiumCompany Announcements
4D Molecular Therapeutics Expands Leadership With New Director Appointment
6M ago
8K
FDMT
4D Molecular Therapeutics: Encouraging Early CF Gene Therapy Signals Tempered by Limited Data, Supporting a Neutral Hold Rating
PremiumRatings4D Molecular Therapeutics: Encouraging Early CF Gene Therapy Signals Tempered by Limited Data, Supporting a Neutral Hold Rating
7M ago
FDMT
4D Molecular announces interim data from 4D-710 Phase 1 AEROW trial
Premium
The Fly
4D Molecular announces interim data from 4D-710 Phase 1 AEROW trial
7M ago
FDMT
4D Molecular Therapeutics Expands Phase 3 Trial Enrollment
Premium
Company Announcements
4D Molecular Therapeutics Expands Phase 3 Trial Enrollment
7M ago
8K
FDMT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >